Cargando…

Correction to: Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous venovenous hemofiltration

Detalles Bibliográficos
Autores principales:	Jacobs, Rita, Honore, Patrick M., Diltoer, Marc, Spapen, Herbert D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093943/ https://www.ncbi.nlm.nih.gov/pubmed/32209066 http://dx.doi.org/10.1186/s12882-020-01749-1

Ejemplares similares

Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration
por: Jacobs, Rita, et al.
Publicado: (2016)

A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients
por: Leung, Anne Kit-Hung, et al.
Publicado: (2013)

Treatment of Ventilator-associated Pneumonia with High-dose Colistin Under Continuous Veno-venous Hemofiltration
por: Spapen, Herbert, et al.
Publicado: (2019)

Correction to: CO(2) and O(2) removal during continuous veno-venous hemofiltration: a pilot study
por: Jonckheer, Joop, et al.
Publicado: (2019)

Experiences with Continuous Venovenous Hemofiltration using 18mmol/L predilution Citrate anticoagulation and a Phosphate Containing Replacement Solution
por: Jeffrey, Yuen Henry, et al.
Publicado: (2017)

Metabolic Acidosis and Hyperlactatemia Requiring Continuous Venovenous Hemofiltration after Intentional Ingestion of Metformin
por: Cruz, Maricel Dela, et al.
Publicado: (2021)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study
por: Yu, Yan, et al.
Publicado: (2020)

Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study
por: Yu, Yan, et al.
Publicado: (2020)

Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial
por: Ratanarat, Ranistha, et al.
Publicado: (2023)

Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?
por: Honore, Patrick M., et al.
Publicado: (2015)

Negative calcium balance despite normal plasma ionized calcium concentrations during citrate anticoagulated continuous venovenous hemofiltration (CVVH) in ICU patients
por: de Jonge, Evert, et al.
Publicado: (2022)

CO(2) and O(2) removal during continuous veno-venous hemofiltration: a pilot study
por: Jonckheer, Joop, et al.
Publicado: (2019)

Acute respiratory muscle weakness and apnea in a critically ill patient induced by colistin neurotoxicity: key potential role of hemoadsorption elimination during continuous venovenous hemofiltration
por: Honore, Patrick M, et al.
Publicado: (2013)

The effects of continuous venovenous hemofiltration on coagulation activation
por: Bouman, Catherine SC, et al.
Publicado: (2006)

Regional citrate anticoagulation in high-volume continuous venovenous hemodialysis
por: Kalb, R, et al.
Publicado: (2011)

Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial
por: Schilder, Louise, et al.
Publicado: (2014)

Regional citrate anticoagulation with a substitute containing calcium for continuous hemofiltration in children
por: Bai, Ke, et al.
Publicado: (2019)

The removal of cystatin C during continuous venovenous hemofiltration
por: Bouman, Catherine S. C., et al.
Publicado: (2011)

Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2009)

Dynamics of the dosage of citrate-calciuminfusion regimens as anticoagulation in continuous venovenous hemodiafiltration
por: Marin Mateos, H, et al.
Publicado: (2015)

Comparing adsorption of gentamicin by polyacrylonitrile and polyamide hemofiltration filter in an in vitro continuous venovenous hemofiltration model
por: Lam, P, et al.
Publicado: (2009)

Renal tubular acidosis with hyperchloremic acidosis: harmless with a sting?
por: Honore, Patrick M., et al.
Publicado: (2015)

Influence of continuous venovenous hemofiltration on transpulmonary thermodilution-derived parameters
por: Neirynck, V, et al.
Publicado: (2009)

Methotrexate toxicity treated with continuous venovenous hemofiltration, leucovorin and glucarpidase
por: Connors, Nicholas J., et al.
Publicado: (2014)

Bioenergetic Balance of Continuous Venovenous Hemofiltration, a Retrospective Analysis
por: Jonckheer, Joop, et al.
Publicado: (2022)

Regional citrate anticoagulation (RCA) for continuous venovenous hemodiafiltration (CVVHDF): initial experience
por: Durão, M, et al.
Publicado: (2001)

Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
por: Lenga, Ilan, et al.
Publicado: (2019)

Some metabolic issues should not be neglected when using citrate for continuous renal replacement therapy!
por: Jacobs, Rita, et al.
Publicado: (2015)

Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
por: Meyer, B, et al.
Publicado: (2004)

Immunomodulatory Effect of Continuous Venovenous Hemofiltration during Sepsis: Preliminary Data
por: Servillo, Giuseppe, et al.
Publicado: (2013)

Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011)

Rapid calcium loss may cause arrhythmia in hemofiltration with regional citrate anticoagulation: a case report
por: Wu, Buyun, et al.
Publicado: (2018)

Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation
por: Margraf, Andreas, et al.
Publicado: (2022)

Putative novel mediators of acute kidney injury in critically ill patients: handling by continuous venovenous hemofiltration and effect of anticoagulation modalities
por: Schilder, Louise, et al.
Publicado: (2015)

Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
por: Slowinski, Torsten, et al.
Publicado: (2015)

Continuous venovenous hemofiltration versus extended daily hemofiltration in patients with septic acute kidney injury: a retrospective cohort study
por: Sun, Zhiping, et al.
Publicado: (2014)

Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
por: dos Santos, Thais Oliveira Claizoni, et al.
Publicado: (2023)

Metabolic and coagulation effects of citrate: down to the last detail!
por: Honore, Patrick M., et al.
Publicado: (2015)

Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study
por: de Pont, Anne-Cornélie JM, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ag3cf0gotd4uqgutksbn5639l9